DLX1 and posterior cortical atrophy: Integrative omics approaches such as Tracing Enhancer Networks using Epigenetic Traits (TENET) have identified DLX1 to be associated with over hundred tumor-specific active enhancers in primary PCa patients, thereby implicating the significance of the extensive DLX1 cistrome that contributes to tumor progression23.